Fundz

ME Therapeutics has closed an over-subscribed private placement, securing $576,500.60. The funding will support the development of its novel cancer-fighting drugs.

PRIVATEJul 17, 2026

Amount Raised

C$577,000

Round Type

Post-IPO Equity

VancouverBiotechnologyHealth CareTherapeutics

Description

ME Therapeutics Holdings Inc. announced the closing of its non-brokered private placement, raising a total of $576,500.60. This financing is aimed at supporting its efforts in developing innovative therapies for cancer treatment. The company continues to advance its mission of reprogramming immune cells to combat cancer

Quick answer

ME Therapeutics Holdings raised C$577,000 in a Post-IPO Equity round, dated July 17, 2026. ME Therapeutics Holdings is based in Vancouver, British Columbia, Canada.

How much did ME Therapeutics Holdings raise?
ME Therapeutics Holdings raised C$577,000 in a Post-IPO Equity round on July 17, 2026.
What does ME Therapeutics Holdings do?
ME Therapeutics is a preclinical stage biotechnology company based in Vancouver, focused on the discovery and development of novel immuno-oncology therapeutics targeting immune suppression in cancer.
Where is ME Therapeutics Holdings based and how big is it?
ME Therapeutics Holdings is based in Vancouver, British Columbia, Canada. Fundz records about 6 employees.
Who are the decision-makers at ME Therapeutics Holdings?
Fundz holds 1 contact at ME Therapeutics Holdings, including the Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as ME Therapeutics Holdings that raised within 45 days of this round, from Fundz verified event records.

  • EIT Pharma raised $35M (Series A) on August 31, 2026.
  • PANDA Therapeutics raised $185K (Pre-Seed) on August 31, 2026.
  • AusperBio raised $120M (Series C) on August 28, 2026.
  • Redx raised $36M (Series A) on August 27, 2026.
  • BioLineRx Ltd raised $3.8M on August 27, 2026.
  • Revier Therapeutics raised $7M (Seed) on August 25, 2026.

Who to call at ME Therapeutics Holdings, and when

A new round usually means ME Therapeutics Holdings is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ME Therapeutics Holdings raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ME Therapeutics Holdings, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ME Therapeutics Holdings. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ME Therapeutics Holdings

Location

Vancouver, British Columbia, Canada

About

ME Therapeutics is a preclinical stage biotechnology company based in Vancouver, focused on the discovery and development of novel immuno-oncology therapeutics targeting immune suppression in cancer. The company's main focus is on overcoming the suppressive effects of myeloid cells to enhance anti-cancer immunity.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ME Therapeutics Holdings raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJohn, Co-Founder hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for ME Therapeutics Holdings's next move

See what Strategic adds

ME Therapeutics Holdings raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.